Dr. Nathan Moore, a well-known Colorado physician, has opened the door to what he predicts will be the first of many addiction treatment centers specializing in rapid addiction detox and recovery for opiate and other harmful addictions. The new treatment center is named the Addiction Recovery Center for Healing aka ARCH Detox, and will open in Aurora, Colo., this month.
“People are dying in record numbers, both on the streets and in their homes of overdoses of prescription painkillers and heroin,” said Dr. Moore. “We need cost-effective and proven treatment options for patients employing leading edge medical protocols to help combat this escalating problem. Opiate abuse is an epidemic that is growing and will not go away.”
The opiate abuse epidemic has garnered national attention in the 2016 presidential campaign by both parties on the election trail. ARCH Detox offers an effective program that provides patients an alternative to a one-to-three month residential treatment program.
“Unfortunately, not all addicts have the luxury of being able to afford a one-to-three month residential treatment program to address their addictions,” said Dr. Moore.
Detoxification from opioid medications and heroin is not cheap. Most detoxification programs are inpatient and require intensive outpatient therapy or inpatient rehab. These programs can easily cost patients $30,000. Many of these programs are not as effective as they claim to be in treating addiction and the value for patients is not there, according to Dr. Moore. He anticipates the cost of his treatment program to be much more affordable for patients, in the $5,000 - $8,000 range, and this would include monthly visits at the Center for a year, as well as thirty visits with a psychologist.
“Our goal is to offer an affordable and effective treatment option for patients.” Dr. Moore said. “This is entirely possible, and we are committed to help with this statewide and national epidemic of opioid abuse.”
Dr. Moore has developed his own proprietary protocol, the “ARCH Detoxification Protocol,” based, in part, on substantial research from his alma mater, Duke University School of Medicine. The ARCH Detoxification Protocol is designed to minimize withdrawal symptoms while flushing opioid drugs out of the patient’s body. The ARCH Detoxification Protocol can be accomplished in an outpatient setting and employs a novel approach with established detoxification medications in a unique manner designed to wean the patient off any opioid drug over a few days. Dr. Moore reports positive results from his ARCH Detoxification Protocol thus far. “Our patients are indicating that they will never go back to opiate abuse. As long as they stick to the protocol, they will do well, ” he said.
“For our patients struggling with opiate addiction, what we’re able to do is get them completely off the addictive substance within a week or with almost zero side-effects. Once the patient is detoxified from their usual opioid drug, our program has hand-selected clinical psychologists who will continue to treat patients with addiction problems to continue in the recovery process.” Moore said, “The recovery component cannot be discounted and is the most important aspect of freeing a patient from addiction. Our program focuses on the individual, and his or her personal history of helplessness, which is what leads many individuals to turn to drugs in the first place.”
Dr. Moore, a member of ASAM, the American Society of Addiction Medicine, became certified to prescribe Suboxone, a synthetic opiate used to treat painkiller and heroin addiction, many years ago after he noticed numerous patients becoming dependent upon opioid painkillers. “I couldn't keep prescribing painkillers to them in good conscience,” he says. “After starting Suboxone, most of my patients come back to see me in tears, saying they have their life back.” Dr. Moore is convinced that there is more that can be done to treat patients that are victimized by this addiction epidemic.
In 2007, Dr. Moore was a recipient of the Ernst & Young Entrepreneur of the Year Award, which he received for the successful launch of his nine-location urgent care and family medicine business, Rocky Mountain Urgent Care and Family Medicine, which he sold in 2013. Dr. Moore was a pioneer in starting the now prolific urgent care industry. Dr. Moore currently is the owner of MedNOW Clinics with two locations in Denver and Aurora. ARCH Detox is a new business venture that will operate separately from his MedNOW Clinics. Dr. Moore expects to open a second ARCH Detox within a year and a third on the west side of town within two years.
Dr. Moore attended Stanford University, obtaining a bachelor of science in 1991, and then Duke University School of Medicine, obtaining his MD in 1995. He also attended the prestigious Woodberry Forest Boarding School in Virginia, graduating summa cum laude in the class of 1987.
Among greater Denver treatment admissions (including alcohol), prescription opioids/opiates other than heroin ranked sixth in the first halves of both 2012 and 2013. Statewide, primary admissions for prescription opioids/opiates other than heroin rose from 2.6 to 7.3 percent of total treatment admissions from 2004 through the first half of 2013. Similarly, in the Denver area, the percentage of primary prescription opioids/opiates other than heroin admissions increased from 3.3 to 6.4 percent of total admissions from 2004 through the first half of 2013. Prescription opioids/opiates other than heroin ranked second in Denver substance abuse-related hospital discharges in 2011, excluding alcohol (n=1,516; rate per 100,000 population=244); both the number and rate of discharges increased in 2012 (n=1,654; rate per 100,000=263).
In the first half of 2013, heroin ranked fourth in statewide treatment admissions (the same as in the first half of 2012) and increased to 9.1 percent of total admissions (including alcohol) from 7.6 percent in the first half of 2012. Denver area primary heroin treatment admissions also increased, from 10.9 percent of the total (including alcohol) in the first half of 2012 to 12.7 percent in the first half of 2013. This increase resulted in a change in rank for heroin from fourth in the first half of 2012 (behind alcohol, marijuana, and methamphetamine) to third in the first half of 2013 (behind alcohol and marijuana but ahead of methamphetamine).